Evidence map›Paper›PMID 9819387›Full record

ArticleMolecular and cellular biology1998

Regulation of RasGRP via a phorbol ester-responsive C1 domain.

C E Tognon, H E Kirk, L A Passmore, I P Whitehead, C J Der, R J Kay

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 232 citations in OpenAlex.

  1. Diacylglycerol kinase is a keystone regulator of signaling relevant to the pathophysiology of asthma.American journal of physiology. Lung cellular and molecular physiology · 2024
    Review
  2. Review
  3. Review
  4. CaProtein science : a publication of the Protein Society · 2022
    Article
  5. Article
  6. Article
  7. In vitro differentiation of W8B2Cellular & molecular biology letters · 2020
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. The Immunomodulatory Functions of Diacylglycerol Kinase ζ.Frontiers in cell and developmental biology · 2016
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

C E TognonTerry Fox Laboratory, British Columbia Cancer Agency, Vancouver, British Columbia, Canada V5Z 4E6.
H E Kirk
L A Passmore
I P Whitehead
C J Der
R J Kay
BC Cancer Agency · CAUniversity of North Carolina at Chapel Hill · USUniversity of British Columbia · CA

Funding

BIOLOGICAL ACTIVITY OF RAS ONCOGENESR01CA042978 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DER, CHANNING J. · 1986 to 2017
$5.9M
RHO FAMILY PROTEINS AND MALIGNANT TRANSFORMATIONR01CA063071 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DER, CHANNING J · 1994 to 2007
$2.0M
FUNCTION OF RAS ONCOGENE PROTEIN RELATED RAB PROTEINSR01CA055008 · NCI · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI DER, CHANNING J · 1991 to 1995
–
NCI NIH HHS CA42978NCI NIH HHS CA55008NCI NIH HHS CA63071NCI NIH HHS R01 CA042978NCI NIH HHS R01 CA063071
6 · The paper itself

Abstract

As part of a cDNA library screen for clones that induce transformation of NIH 3T3 fibroblasts, we have isolated a cDNA encoding the murine homolog of the guanine nucleotide exchange factor RasGRP. A point mutation predicted to prevent interaction with Ras abolished the ability of murine RasGRP (mRasGRP) to transform fibroblasts and to activate mitogen-activated protein kinases (MAP kinases). MAP kinase activation via mRasGRP was enhanced by coexpression of H-, K-, and N-Ras and was partially suppressed by coexpression of dominant negative forms of H- and K-Ras. The C terminus of mRasGRP contains a pair of EF hands and a C1 domain which is very similar to the phorbol ester- and diacylglycerol-binding C1 domains of protein kinase Cs. The EF hands could be deleted without affecting the ability of mRasGRP to transform NIH 3T3 cells. In contrast, deletion of the C1 domain or an adjacent cluster of basic amino acids eliminated the transforming activity of mRasGRP. Transformation and MAP kinase activation via mRasGRP were restored if the deleted C1 domain was replaced either by a membrane-localizing prenylation signal or by a diacylglycerol- and phorbol ester-binding C1 domain of protein kinase C. The transforming activity of mRasGRP could be regulated by phorbol ester when serum concentrations were low, and this effect of phorbol ester was dependent on the C1 domain of mRasGRP. The C1 domain could also confer phorbol myristate acetate-regulated transforming activity on a prenylation-defective mutant of K-Ras. The C1 domain mediated the translocation of mRasGRP to cell membranes in response to either phorbol ester or serum stimulation. These results suggest that the primary mechanism of activation of mRasGRP in fibroblasts is through its recruitment to diacylglycerol-enriched membranes. mRasGRP is expressed in lymphoid tissues and the brain, as well as in some lymphoid cell lines. In these cells, RasGRP has the potential to serve as a direct link between receptors which stimulate diacylglycerol-generating phospholipase Cs and the activation of Ras.

Indexed as

Guanine Nucleotide Exchange FactorsAmino Acid SequenceAnimalsBase SequenceCalcium-Calmodulin-Dependent Protein KinasesCell LineDNA-Binding ProteinsDNA, ComplementaryDNA Mutational AnalysisEnzyme ActivationGene ExpressionHumansMiceMicroscopy, FluorescenceMolecular Sequence DataPoint MutationCalcium-Calmodulin-Dependent Protein KinasesDNA-Binding ProteinsDNA, ComplementaryGuanine Nucleotide Exchange FactorsRASGRP1 protein, humanRasgrp1 protein, mouseRNA, MessengerTetradecanoylphorbol Acetate

Identifiers

PMID9819387
PMCPMC109282
OpenAlexW2121401590

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.